Diagnostic procedures and treatment of patients with Myelodysplastic Syndromes (MDS) in outpatient clinics - results of the outpatient MDS registry

被引:0
|
作者
Schmitz, S. [1 ]
Boettger, I [1 ]
Welslau, M. [1 ]
Lerchenmueller, C. [1 ]
Sauer, A. [1 ]
Germing, U. [1 ]
机构
[1] Univ Klin Dusseldorf, Dusseldorf, Germany
来源
ONKOLOGIE | 2011年 / 34卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:289 / 289
页数:1
相关论文
共 50 条
  • [41] Evidence for Selective Benefit of Sequential Treatment with Azanucleosides in Patients with Myelodysplastic Syndromes (MDS)
    Apuri, Susmitha
    Lancet, Jeffrey E.
    Al Ali, Najla H.
    Padron, Eric
    Ho, Viet Q.
    Pinilla-Ibarz, Javier
    List, Alan F.
    Komrokji, Rami S.
    BLOOD, 2012, 120 (21)
  • [42] Evidence for selective benefit of sequential treatment with azanucleosides in patients with myelodysplastic syndromes (MDS)
    Komrokji, Rami S.
    Apuri, Susmitha
    Al Ali, Najla
    Padron, Eric
    Pinilla-Ibarz, Javier
    Ho, Viet
    List, Alan F.
    Lancet, Jeffrey E.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] HIPERFERRITINEMIA IN MDS PATIENTS- POLISH RETROSPECTIVE MDS REGISTRY Results
    Dwilewicz-Trojaczek, J.
    Madry, K.
    Waszczuk-Gajda, A.
    Stella-Holowiecka, B.
    Mital, A.
    Drozd-Sokolowska, J.
    Wiater, E.
    Kolkowska-Lesniak, A.
    Szmigielska, A.
    Mendrek, W.
    Subocz, E.
    Obara, A.
    Biedron, M.
    Zalewska, M.
    Jachalska, A.
    Kruger, W.
    Katinas, K.
    Guzicka-Kazimierczak, R.
    Wasilewska, E.
    Pedziwiatr, M.
    Nowicki, A.
    Kopacz, A.
    Nowak, E.
    Blasiak, A.
    Wojciechowska, M.
    Soroka-Wojtaszko, M.
    Sedzimirska, M.
    Gornik, S.
    HAEMATOLOGICA, 2012, 97 : 579 - 579
  • [44] DELETION 5Q MYELODYSPLASTIC SYNDROMES (MDS) TREATMENT AND DIAGNOSTIC PATTERNS IN MEXICO: RESULTS FROM A PHYSICIAN SURVEY
    Hernandez-Perez, C.
    Kassack-Ipina, J.
    Soriano, M.
    Arnold, R.
    Mahmoud, D.
    HAEMATOLOGICA, 2013, 98 : 586 - 586
  • [45] BIOSIMILAR EPOETIN ZETA FOR THE TREATMENT OF ANEMIA IN MYELODYSPLASTIC SYNDROMES (MDS)
    Pelizzari, A.
    Ferrero, D.
    Molteni, A.
    Allione, B.
    Mezzabotta, M.
    Clavio, M.
    Borlenghi, E.
    Rossi, G.
    Masiera, E.
    Santini, V.
    LEUKEMIA RESEARCH, 2015, 39 : S56 - S57
  • [46] Myelodysplastic syndromes (MDS): An international practice and treatment survey.
    List, AF
    BLOOD, 2005, 106 (11) : 712A - 712A
  • [47] Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry
    Hoeks, Marlijn
    Yu, Ge
    Langemeijer, Saskia
    Crouch, Simon
    de Swart, Louise
    Fenaux, Pierre
    Symeonidis, Argiris
    Cermak, Jaroslav
    Hellstrom-Lindberg, Eva
    Sanz, Guillermo
    Stauder, Reinhard
    Holm, Mette Skov
    Mittelman, Moshe
    Madry, Krzysztof
    Malcovati, Luca
    Tatic, Aurelia
    Almeida, Antonio Medina
    Germing, Ulrich
    Savic, Aleksandar
    Simec, Njetocka Gredelj
    Culligan, Dominic
    Itzykson, Raphael
    Guerci-Bresler, Agnes
    Slama, Borhane
    van de Loosdrecht, Arjan
    van Marrewijk, Corine
    Droste, Jackie
    Blijlevens, Nicole
    van Kraaij, Marian
    Bowen, David
    de Witte, Theo
    Smith, Alex
    HAEMATOLOGICA, 2020, 105 (03) : 640 - 651
  • [48] Incidence and prevalence of myelodysplastic syndromes: Data from the Dusseldorf MDS-registry
    Neukirchen, Judith
    Schoonen, Wilma M.
    Strupp, Corinna
    Gattermann, Norbert
    Aul, Carlo
    Haas, Rainer
    Germing, Ulrich
    LEUKEMIA RESEARCH, 2011, 35 (12) : 1591 - 1596
  • [49] A PHASE II STUDY OF OUTPATIENT ADMINISTRATION OF DECITABINE FOR 5 DAYS EVERY 4 WEEKS TO ADULTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    Steensma, P.
    Baer, M.
    Slack, J.
    Buckstein, R.
    Godley, L.
    Larsen, J.
    Cullen, M.
    Arora, S.
    Kantarjian, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 90 - 90
  • [50] Diagnostic Testing Patterns for Ring Sideroblasts (RS) in Patients with Newly Diagnosed Lower-Risk Myelodysplastic Syndromes (LR-MDS) in the Connect® MDS/AML Disease Registry
    Patel, Jay
    Cogle, Christopher
    Foucar, Kathryn
    Grinblatt, David
    Komrokji, Rami
    Savona, Michael
    Scott, Bart
    Sekeres, Mikkael
    Steensma, David
    Flick, Dawn
    Kiselev, Pavel
    Louis, Chrystal
    Nifenecker, Melissa
    Swern, Arlene
    George, Tracy
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S343 - S344